These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22616647)

  • 21. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.
    Nwobegahay J; Selabe G; Ndjeka NO; Manhaeve C; Bessong PO
    J Med Virol; 2012 Dec; 84(12):1839-43. PubMed ID: 23080485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.
    Hamers RL; Siwale M; Wallis CL; Labib M; van Hasselt R; Stevens WS; Schuurman R; Wensing AM; Van Vugt M; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):95-101. PubMed ID: 20585262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil.
    Barreto CC; Nishyia A; Araújo LV; Ferreira JE; Busch MP; Sabino EC
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):338-41. PubMed ID: 16540943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.
    MacVeigh MS; Kosmetatos MK; McDonald JE; Reeder JL; Parrish DA; Young TP
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):337-42. PubMed ID: 22697610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.
    Hassan AS; Mwaringa SM; Obonyo CA; Nabwera HM; Sanders EJ; Rinke de Wit TF; Cane PA; Berkley JA
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):129-35. PubMed ID: 22900472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China.
    Wang X; He C; Xing H; Liao L; Xu X; He J; Liu Y; Ling H; Liang S; Hsi JH; Ruan Y; Shao Y
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1637-9. PubMed ID: 22822770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala.
    Ndembi N; Hamers RL; Sigaloff KC; Lyagoba F; Magambo B; Nanteza B; Watera C; Kaleebu P; Rinke de Wit TF
    AIDS; 2011 Apr; 25(7):905-10. PubMed ID: 21399479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.
    Lunar MM; Židovec Lepej S; Abecasis AB; Tomažič J; Vidmar L; Karner P; Vovko TD; Pečavar B; Maver PJ; Seme K; Poljak M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):343-9. PubMed ID: 22860694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi.
    Bansode V; Drebert ZJ; Travers SA; Banda E; Molesworth A; Crampin A; Ngwira B; French N; Glynn JR; McCormack GP
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):439-44. PubMed ID: 20950147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort.
    Payne BA; Nsutebu EF; Hunter ER; Olarinde O; Collini P; Dunbar JA; Basta MS; Elston JW; Schmid ML; Thaker H; Chadwick DR
    J Antimicrob Chemother; 2008 Sep; 62(3):464-8. PubMed ID: 18552342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods.
    Hunt GM; Ledwaba J; Kalimashe M; Salimo A; Cibane S; Singh B; Puren A; Dean NE; Morris L; Jordan MR
    Antivir Ther; 2019; 24(3):203-210. PubMed ID: 30741163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
    Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
    J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.
    Panichsillapakit T; Smith DM; Wertheim JO; Richman DD; Little SJ; Mehta SR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):228-36. PubMed ID: 26413846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.